RBC Capital Reiterates Sector Perform on Medtronic, Maintains $92 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh has reiterated a Sector Perform rating on Medtronic (NYSE:MDT) and maintained a price target of $92.
June 05, 2024 | 2:49 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
RBC Capital has reiterated a Sector Perform rating on Medtronic and maintained a price target of $92.
The reiteration of a Sector Perform rating and maintenance of the price target at $92 suggests that RBC Capital does not see significant short-term changes in Medtronic's stock price. This is a neutral signal for investors.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100